Accomplishments in 2008 in the management of gastrointestinal neuroendocrine tumors.

ABSTRACT: Overview of the Disease ProcessIncidencePrognostic FactorsGeneral Therapy StandardsAccomplishments and Lack of Accomplishments During the YearSomatostatin AnalogsPeptide Receptor-Targeted TherapySelective Internal Radiotherapy (SIRT)CYTOTOXIC THERAPIES: TemozolomideVEGF Pathway InhibitorsmTOR InhibitorsDevelopment of BiomarkersWhat Needs to be Done (Application of the Accomplishments)Controversies and DisagreementsHistologic Classification and Staging of Neuroendocrine TumorsClinical Trial Design and End PointsFuture Directions.

SUBMITTER: Kulke MH 

PROVIDER: S-EPMC2791386 | biostudies-literature | 2009 Sep

REPOSITORIES: biostudies-literature